We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
Turnover
22.64%
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$927M
AUM Growth
-$1.43M
(-0.15%)
Cap. Flow
+$7.24M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
60.5%
Holding
125
New
10
Increased
26
Reduced
9
Closed
9
Avg Time Held
2.1
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$11.3M |
| 2 |
Wells Fargo
WFC
|
+$9.14M |
| 3 |
ExxonMobil
XOM
|
+$3.7M |
| 4 |
3M
MMM
|
+$2.2M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$2.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$9.37M |
| 2 |
Wabtec
WAB
|
+$5.68M |
| 3 |
Procter & Gamble
PG
|
+$4.97M |
| 4 |
General Mills
GIS
|
+$3.54M |
| 5 |
CELG
Celgene Corp
CELG
|
+$3.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.92% |
| 2 | Healthcare | 20.06% |
| 3 | Miscellaneous | 11.58% |
| 4 | Industrials | 8.62% |
| 5 | Materials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SRRA
101
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $195K | 0.02% |
12,503
+6,200
| +98% | +$119K |
2018 Q4
3 quarters
|
|
102
DELISTED
TEGNA Inc
TGNA
| $189K | 0.02% |
12,180
| – | – |
2018 Q2
5 quarters
|
|
103
GrafTech
EAF
$185M
| $181K | 0.02% |
1,415
| – | – |
2019 Q2
1 quarter
|
|
|
SPHS
104
DELISTED
Sophiris Bio, Inc.
SPHS
| $176K | 0.02% |
300,900
| – | – |
2018 Q3
4 quarters
|
|
|
CALA
105
DELISTED
Calithera Biosciences, Inc
CALA
| $155K | 0.02% |
2,500
| – | – |
2018 Q2
5 quarters
|
|
|
MDR
106
DELISTED
McDermott International
MDR
| $153K | 0.02% |
75,600
| – | – |
2018 Q2
5 quarters
|
|
107
Innoviva
INVA
$1.5B
| $151K | 0.02% |
14,340
| – | – |
2019 Q2
1 quarter
|
|
|
MIK
108
DELISTED
Michaels Stores, Inc
MIK
| $151K | 0.02% |
15,450
| – | – |
2018 Q2
5 quarters
|
|
109
Larimar Therapeutics
LRMR
$207M
| $148K | 0.02% |
16,718
+4,175
| +33% | +$45.8K |
2018 Q4
3 quarters
|
|
110
DELISTED
Mersana Therapeutics
MRSN
| $143K | 0.02% |
3,610
| – | – |
2018 Q4
3 quarters
|
|
111
GameStop
GME
$13.5B
| $122K | 0.01% |
88,480
| – | – |
2019 Q2
1 quarter
|
|
|
FTSI
112
DELISTED
FTS International, Inc. Common Stock
FTSI
| $42K | ﹤0.01% |
932
| – | – |
2019 Q2
1 quarter
|
|
113
Acadia Pharmaceuticals
ACAD
$3.29B
| – | – |
-18,535
| Closed | -$495K | – |
|
114
HP
HPQ
$27.1B
| – | – |
-9,790
| Closed | -$204K | – |
|
115
H&R Block
HRB
$5.96B
| – | – |
-7,590
| Closed | -$222K | – |
|
116
ManpowerGroup
MAN
$1.93B
| – | – |
-2,300
| Closed | -$222K | – |
|
117
Nektar Therapeutics
NKTR
$1.22B
| – | – |
-393
| Closed | -$210K | – |
|
118
Viking Therapeutics
VKTX
$3.2B
| – | – |
-50,000
| Closed | -$415K | – |
|
119
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-167
| Closed | -$23K | – |
|
|
MTOR
120
DELISTED
MERITOR, Inc.
MTOR
| – | – |
-8,470
| Closed | -$205K | – |
|
Similar funds
TPW
EWA
DCM
BC
QIM
AIMC
F
AAM
Hikari Power's Q3 2019 Portfolio in Review
As of Q3 2019, Hikari Power held 125 positions worth $927M, down 0.15% from $928M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Hikari Power's Q3 2019 filing shows 10 new, 26 increased, 9 reduced and 9 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M. The largest sale was Colgate-Palmolive, an estimated $9.37M.
By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Miscellaneous.
- Hikari Power's largest Q3 2019 buy was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M.
- Hikari Power added most to Wells Fargo in Q3 2019, an estimated $9.14M increase.
- Hikari Power's biggest Q3 2019 reduction was Colgate-Palmolive, cutting an estimated $9.37M.
- Hikari Power fully exited Acadia Pharmaceuticals in Q3 2019, selling an estimated $495K.
- Hikari Power's ten largest holdings make up 61% of its $927M portfolio in Q3 2019.
- Hikari Power opened 10 new positions and closed 9 in Q3 2019.
- Hikari Power's portfolio value fell 0.15% quarter-over-quarter to $927M.
Based on Hikari Power's 13F filing for Q3 2019, filed 31 Oct 2019.